Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;115:2497-2505
Published online before print May 7, 2007, doi: 10.1161/CIRCULATIONAHA.106.633180
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Circulation: May 15, 2007, Volume 115, Number 19
Right arrow Data Supplement
Right arrow All Versions of this Article:
115/19/2497    most recent
CIRCULATIONAHA.106.633180v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maybaum, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maybaum, S.
Related Collections
Right arrow Congestive
Right arrow Remodeling
Right arrow Heart failure - basic studies
Right arrow CV surgery: transplantation, ventricular assistance, cardiomyopathy
Right arrowRelated Article

(Circulation. 2007;115:2497-2505.)
© 2007 American Heart Association, Inc.


Heart Failure

Cardiac Improvement During Mechanical Circulatory Support

A Prospective Multicenter Study of the LVAD Working Group

Simon Maybaum, MD; Donna Mancini, MD*; Steve Xydas, MD*; Randall C. Starling, MD, MPH; Keith Aaronson, MD, MS; Francis D. Pagani, MD, PhD; Leslie W. Miller, MD; Kenneth Margulies, MD; Susan McRee, RN, BSN; O.H. Frazier, MD; Guillermo Torre-Amione, MD, PhD, for the LVAD Working Group

From Albert Einstein College of Medicine, Bronx, NY (S.M.); Columbia University College of Physicians and Surgeons, New York, NY (D.M., S.X.); Cleveland Clinic, Cleveland, Ohio (R.C.S.); University of Michigan Health System, Ann Arbor (K.A., F.D.P.); University of Minnesota, Minneapolis (L.W.M.); University of Pennsylvania, Philadelphia (K.M.); Texas Heart Institute, Houston (O.H.F.); and Methodist DeBakey Heart Center, Baylor College of Medicine, Houston, Tex (S.M., G.T.-A.). Dr Miller is currently at the Georgetown Hospital Center, Washington, DC.

Correspondence to Simon Maybaum, MD, Albert Einstein College of Medicine, Center for Advanced Cardiac Therapy, 3400 Bainbridge Ave, 7th Floor, Bronx, NY 10467-2490. E-mail smaybaum{at}montefiore.org

Received July 31, 2006; accepted March 4, 2007.

Background— Myocardial recovery after left ventricular assist device (LVAD) support has been reported. The LVAD Working Group Recovery Study was a prospective multicenter trial to assess the incidence of myocardial recovery in patients bridged to cardiac transplantation.

Methods and Results— After LVAD implantation, patients were evaluated with the use of rest echocardiograms with partial LVAD support and cardiopulmonary exercise testing. Dobutamine echocardiography with hemodynamic measurements was performed in those patients with left ventricular ejection fraction >40% during resting studies. Histological analysis was performed on myocardial samples taken at LVAD implantation and explantation. Sixty-seven LVAD patients with heart failure participated in the study. After 30 days, significant improvement occurred in left ventricular ejection fraction (17±7% versus 34±12%; P<0.001) and reductions in left ventricular end-diastolic diameter (7.1±1.2 versus 5.1±1.1 cm; P<0.001) and left ventricular mass (320±113 versus 194±79 g; P<0.001) compared with before LVAD. Thirty-four percent of patients had left ventricular ejection fraction >40% with partial device support. Left ventricular ejection fraction decreased over time to pre-LVAD measurement by 120 days. Peak VO2 improved with mechanical support (13.7±4.2 versus 18.9±5.5 mL/kg per minute, 30 versus 120 days; P<0.001). Tissue analysis revealed significant reductions in myocyte size, collagen content, and cardiac tumor necrosis factor-{alpha}. Six subjects (9%) underwent LVAD explantation for recovery.

Conclusions— Cardiac function improves significantly after device implantation. Although cellular recovery and improvement in ventricular function are observed, the degree of clinical recovery is insufficient for device explantation in most patients with chronic heart failure.


 

CLINICAL PERSPECTIVE


Related Article:

Issue Highlights
Circulation 2007 115: 2459. [Extract] [Full Text]



This article has been cited by other articles:


Home page
Circ Heart FailHome page
K. R. McGaffin, C. S. Moravec, and C. F. McTiernan
Leptin Signaling in the Failing and Mechanically Unloaded Human Heart
Circ Heart Fail, November 1, 2009; 2(6): 676 - 683.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S. Klotz, D. Burkhoff, I. M. Garrelds, F. Boomsma, and A.H.J. Danser
The impact of left ventricular assist device-induced left ventricular unloading on the myocardial renin-angiotensin-aldosterone system: therapeutic consequences?
Eur. Heart J., April 1, 2009; 30(7): 805 - 812.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. S. Willis, M. Rojas, L. Li, C. H. Selzman, R.-H. Tang, W. E. Stansfield, J. E. Rodriguez, D. J. Glass, and C. Patterson
Muscle ring finger 1 mediates cardiac atrophy in vivo
Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H997 - H1006.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
U. Siedlecka, M. Arora, T. Kolettis, G. K. R. Soppa, J. Lee, M. A. Stagg, S. E. Harding, M. H. Yacoub, and C. M. N. Terracciano
Effects of clenbuterol on contractility and Ca2+ homeostasis of isolated rat ventricular myocytes
Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H1917 - H1926.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. H. Jones
The Year in Cardiovascular Surgery
J. Am. Coll. Cardiol., April 29, 2008; 51(17): 1707 - 1718.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. K.R. Soppa, J. Lee, M. A. Stagg, L. E. Felkin, P. J.R. Barton, U. Siedlecka, S. Youssef, M. H. Yacoub, and C. M.N. Terracciano
Role and possible mechanisms of clenbuterol in enhancing reverse remodelling during mechanical unloading in murine heart failure
Cardiovasc Res, March 1, 2008; 77(4): 695 - 706.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. R. Davies
Invited commentary
Ann. Thorac. Surg., October 1, 2007; 84(4): 1262 - 1263.
[Full Text] [PDF]